Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/5/2026

Management Strategies for Eosinophilic Gastritis

Non‑Steroid First‑Line Options

  • For patients who wish to avoid corticosteroids, a regimen combining a twice‑daily proton‑pump inhibitor, dietary modification, and the antihistamine loratadine achieved clinical resolution in approximately 62 % of cases, supporting its use as an initial non‑steroid therapy. 1
  • Implementation of elimination diets should be performed with dietitian support, as recommended by extrapolation from eosinophilic esophagitis guidelines. 1

Escalation to Corticosteroid Therapy

  • In moderate disease or when the non‑steroid regimen fails after 8–12 weeks, escalation to systemic corticosteroids is advised. 2
  • For severe disease or after failure of conservative therapy, prednisolone should be initiated; clinical response should be monitored and the dose tapered as tolerated. 2

Monitoring and Follow‑Up

  • Endoscopic evaluation with gastric biopsies is required to document histologic response because symptom improvement does not reliably correlate with mucosal inflammation. [1][2]

Biologic Therapies for Eosinophilic Gastrointestinal Disorders (Evidence from Gastroenterology 2020)

Anti‑IL‑5 and Anti‑IL‑13 Agents